We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Tosoh Bioscience, an importer of assays and high performance liquid chromatographs, failed to properly manage its suppliers and handle complaints, according to an FDA warning letter. Read More
The FDA and the medical device industry have agreed on the terms for a new medical device reauthorization package that would allow the agency to collect $999.5 million in user fees over the next five years. Read More